The Gemini 2.5 Deep Think released to users is not that same competition model, rather, a lower performing but apparently faster version.

AI-powered drug company spun out of Google’s DeepMind says human trials are ‘very close’ After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials.

Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in ...

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

The Romans created a remarkably organized and well-structured society. A big part of that was writing; they wrote often, and ...

Demis Hassabis, chief of Google DeepMind, believes there's a 50% chance of achieving AGI within 5 years. AGI means ...

Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is ...

A University of Warwick epigraphy expert has collaborated with Google DeepMind to evaluate "Aeneas," an AI model that ...

Two AI models have achieved gold medal standard for the first time in a prestigious competition for young mathematicians – ...

The largest merger of two black holes ever recorded has been detected by astronomers. The collision of the pair, each more ...

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are also racing to use AI in drug discovery.